PT971714E - Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia - Google Patents
Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demenciaInfo
- Publication number
- PT971714E PT971714E PT98912108T PT98912108T PT971714E PT 971714 E PT971714 E PT 971714E PT 98912108 T PT98912108 T PT 98912108T PT 98912108 T PT98912108 T PT 98912108T PT 971714 E PT971714 E PT 971714E
- Authority
- PT
- Portugal
- Prior art keywords
- inhibitors
- dementia
- cyclooxigenase
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4391697P | 1997-04-03 | 1997-04-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT971714E true PT971714E (pt) | 2002-12-31 |
Family
ID=21929578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98912108T PT971714E (pt) | 1997-04-03 | 1998-03-30 | Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0971714B1 (pt) |
| JP (1) | JP2002514208A (pt) |
| AT (1) | ATE225660T1 (pt) |
| AU (1) | AU725697B2 (pt) |
| BR (1) | BR9807920A (pt) |
| CA (1) | CA2285434A1 (pt) |
| DE (1) | DE69808607T2 (pt) |
| DK (1) | DK0971714T3 (pt) |
| ES (1) | ES2185154T3 (pt) |
| HK (1) | HK1024872A1 (pt) |
| PT (1) | PT971714E (pt) |
| WO (1) | WO1998043648A1 (pt) |
| ZA (1) | ZA982808B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6727238B2 (en) | 1998-06-11 | 2004-04-27 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| US6294558B1 (en) | 1999-05-31 | 2001-09-25 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9420616D0 (en) * | 1994-10-12 | 1994-11-30 | Merck Sharp & Dohme | Method, compositions and use |
| NZ336428A (en) * | 1993-11-30 | 2005-02-25 | G | use of substituted pyrazolyl benzosulphonamides to treat inflammation |
| US5486534A (en) * | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
| US5696143A (en) * | 1994-09-20 | 1997-12-09 | Talley; John J. | Benz G! indazolyl derivatives for the treatment of inflammation |
| US5547975A (en) * | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| US5643933A (en) * | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| WO1996038418A1 (en) * | 1995-06-02 | 1996-12-05 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| EP0833622B8 (en) * | 1995-06-12 | 2005-10-12 | G.D. Searle & Co. | Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
| CA2224563A1 (en) * | 1995-06-12 | 1996-12-27 | G.D. Searle & Co. | Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| RO121338B1 (ro) * | 1996-04-12 | 2007-03-30 | G.D. Searle & Co. | Derivaţi de benzensulfonamidă, procedeu de preparare a acestora, compoziţie farmaceutică şi utilizarea ca inhibitori de cox-2 |
-
1998
- 1998-03-30 WO PCT/US1998/006143 patent/WO1998043648A1/en active IP Right Grant
- 1998-03-30 AT AT98912108T patent/ATE225660T1/de not_active IP Right Cessation
- 1998-03-30 DK DK98912108T patent/DK0971714T3/da active
- 1998-03-30 ES ES98912108T patent/ES2185154T3/es not_active Expired - Lifetime
- 1998-03-30 PT PT98912108T patent/PT971714E/pt unknown
- 1998-03-30 DE DE69808607T patent/DE69808607T2/de not_active Expired - Fee Related
- 1998-03-30 EP EP98912108A patent/EP0971714B1/en not_active Expired - Lifetime
- 1998-03-30 JP JP54186898A patent/JP2002514208A/ja not_active Ceased
- 1998-03-30 CA CA002285434A patent/CA2285434A1/en not_active Abandoned
- 1998-03-30 AU AU65904/98A patent/AU725697B2/en not_active Ceased
- 1998-03-30 BR BR9807920-4A patent/BR9807920A/pt not_active IP Right Cessation
- 1998-04-02 ZA ZA982808A patent/ZA982808B/xx unknown
-
2000
- 2000-07-06 HK HK00104146A patent/HK1024872A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69808607T2 (de) | 2003-06-26 |
| DK0971714T3 (da) | 2002-11-04 |
| DE69808607D1 (de) | 2002-11-14 |
| WO1998043648A1 (en) | 1998-10-08 |
| AU6590498A (en) | 1998-10-22 |
| EP0971714A1 (en) | 2000-01-19 |
| HK1024872A1 (en) | 2000-10-27 |
| JP2002514208A (ja) | 2002-05-14 |
| BR9807920A (pt) | 2000-02-22 |
| ZA982808B (en) | 1999-04-06 |
| EP0971714B1 (en) | 2002-10-09 |
| ES2185154T3 (es) | 2003-04-16 |
| ATE225660T1 (de) | 2002-10-15 |
| AU725697B2 (en) | 2000-10-19 |
| CA2285434A1 (en) | 1998-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200200068T2 (tr) | Nematisital triflüorobütenler | |
| WO2001066564A3 (en) | Gamma-secretase inhibitors | |
| ATE225351T1 (de) | Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel | |
| CA2267186A1 (en) | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia | |
| MX9304638A (es) | Composicion para tratar e inhibir las ulceras gastricas y duodenales. | |
| DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
| NO992821L (no) | Ketobenzamider som calpain-inhibitorer | |
| ATE148130T1 (de) | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren | |
| NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
| TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
| DK0981341T3 (da) | Anvendelse af betulinsyrederivater til behandling og forebyggelse af melanom | |
| ATE217865T1 (de) | Verbindungen zur hemmung von phosphodiesrerase iv | |
| WO1999005096A3 (en) | Urokinase inhibitors | |
| DK0842934T3 (da) | 5-HT1F agonister | |
| CY1108110T1 (el) | Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου | |
| ES2191292T3 (es) | Compuestos antivirales poliaromaticos. | |
| DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
| WO1998036730A3 (de) | Zubereitungen für die behandlung von rosacea | |
| CA2270469A1 (en) | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents | |
| CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
| ATE180669T1 (de) | Verwendung von pregnanderivaten zur behandlung von tumoren | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| PT971714E (pt) | Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia | |
| WO2001030334A3 (en) | 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation | |
| CA2372912A1 (en) | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |